Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q3 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Jennifer Viera - Investor Relations Dr. Jay Luly - President and CEO Paul Mellett - Chief Financial Officer Nathalie Adda - Chief Medical Officer Conference Call Participants Brian Skorney - Baird Swapnil Malekar - Piper Sandler Brian Abrahams - RBC Capital Markets Roy Buchanan - JMP Securities Zegbeh Jallah - ROTH Capital Markets Operator Good afternoon. And welcome to Enanta Pharmaceu ...

E N A N T A Pharmaceuticals CREATING SMALL MOLECULE DRUGS FOR VIRAL INFECTIONS AND LIVER DISEASES Corporate Presentation June 22, 2021 Forward Looking Statements Disclaimer This presentation contains forward-looking statements concerning our business, operations and financial performance and condition, as well as our plans, objectives and expectations for our research and development programs, our business and the industry in which we operate. Any statements contained herein that are not statements of histo ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Jennifer Viera - Investor Relations Jay Luly - President and Chief Executive Officer Paul Mellett - Chief Financial Officer Nathalie Adda - Chief Medical Officer Conference Call Participants Brian Abrahams - RBC Capital Markets Yasmeen Rahimi - Piper Sandler Eric Joseph - J.P. Morgan Roy Buchanan - JMP Securities LLC Brian Skorney - Robert W. Baird & Co. William Lee - Wolfe Research, LLC Z ...

E N A N T A Pharmaceuticals CREATING SMALL MOLECULE DRUGS FOR VIRAL INFECTIONS AND LIVER DISEASES Corporate Presentation May 6, 2021 Forward Looking Statements Disclaimer This presentation contains forward-looking statements concerning our business, operations and financial performance and condition, as well as our plans, objectives and expectations for our research and development programs, our business and the industry in which we operate. Any statements contained herein that are not statements of histori ...

E N A N T A Pharmaceuticals CREATING SMALL MOLECULE DRUGS FOR VIRAL INFECTIONS AND LIVER DISEASES Corporate Presentation March 16, 2021 Forward Looking Statements Disclaimer This presentation contains forward-looking statements concerning our business, operations and financial performance and condition, as well as our plans, objectives and expectations for our research and development programs, our business and the industry in which we operate. Any statements contained herein that are not statements of hist ...

E N A N T A Pharmaceuticals CREATING SMALL MOLECULE DRUGS FOR VIRAL INFECTIONS AND LIVER DISEASES Corporate Overview February 25, 2021 Forward Looking Statements Disclaimer This presentation contains forward-looking statements concerning our business, operations and financial performance and condition, as well as our plans, objectives and expectations for our research and development programs, our business and the industry in which we operate. Any statements contained herein that are not statements of histo ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2021 Earnings Conference Call February 8, 2021 4:30 PM ET Company Participants Jennifer Viera - Investor Relations Jay Luly - President & Chief Executive Officer Paul Mellett - Chief Financial Officer Conference Call Participants Roy Buchanan - JMP Securities Rachel Vatnsdal - Piper Sandler Brian Skorney - Baird Brian Abrahams - RBC Capital Markets Jay Olson - Oppenheimer Liisa Bayko - Evercore ISI Eric Joseph - JPMorgan Zegbeh Jallah - ROTH Capital Partners Aka ...

E N A N T A Pharmaceuticals CREATING SMALL MOLECULE DRUGS FOR VIRAL INFECTIONS AND LIVER DISEASES CREATING SMALL MOLECULE DRUGS FOR VIRAL INFECTIONS AND LIVER DISEASES Corporate Overview 39th Annual J.P. Morgan Healthcare Conference January 12, 2021 Forward Looking Statements Disclaimer This presentation contains forward-looking statements concerning our business, operations and financial performance and condition, as well as our plans, objectives and expectations for our research and development programs, ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2020 Earnings Conference Call November 23, 2020 4:30 PM ET Company Participants Jennifer Viera - Senior Director, IR & Corporate Communications Jay Luly - President, CEO & Director Paul Mellett - SVP, Finance & Administration and CFO Conference Call Participants Roy Buchanan - JMP Securities Yasmeen Rahimi - Piper Sandler Eric Joseph - JP Morgan Jay Olson - Oppenheimer Operator Good afternoon and welcome to Enanta Pharmaceuticals fiscal fourth quarter and year-e ...

Corporate Presentation August 4, 2020 ENANTA Pharmaceuticals 1 © 2020 | 1 Pl Creating Small Molecule Drugs for Viral Infections and Liver Diseases Forward Looking Statements Disclaimer This presentation contains forward-looking statements concerning our business, operations and financial performance and condition, as well as our plans, objectives and expectations for our research and development programs, our business and the industry in which we operate. Any statements contained herein that are not stateme ...